
Johnson & Johnson has agreed to purchase clinical-stage biotechnology firm Halda Therapeutics for $3.05 billion in money in a deal that bolsters the healthcare big’s oncology pipeline.
Source link


Johnson & Johnson has agreed to purchase clinical-stage biotechnology firm Halda Therapeutics for $3.05 billion in money in a deal that bolsters the healthcare big’s oncology pipeline.
Source link
:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)



Recent Comments